These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16212372)

  • 21. Antitumor effect of Pt(II) amine phosphonate complexes on sarcoma sa-180 in mice. Crystal structure of cis-dichlorobis(diethyl-4-pyridylmethylphosphonate-kappaN)platinum(II) hydrate, cis-[PtCl2(4-pmpe)2].H20.
    Aranowska K; Graczyk J; Checińska L; Pakulska W; Ochock J
    Pharmazie; 2006 May; 61(5):457-60. PubMed ID: 16724546
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mixed complexes of Pt(II) and Pd(II) with ethylsarcosinedithiocarbamate and 2-/3-picoline as antitumor agents.
    Giovagnini L; Marzano C; Bettio F; Fregona D
    J Inorg Biochem; 2005 Nov; 99(11):2139-50. PubMed ID: 16165215
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Three new asymmetric trans-amine(azole)dichloridoplatinum complexes that overcome cisplatin resistance and their reactions with 5'-GMP.
    Pantoja E; Gallipoli A; van Zutphen S; Komeda S; Reddy D; Jaganyi D; Lutz M; Tooke DM; Spek AL; Navarro-Ranninger C; Reedijk J
    J Inorg Biochem; 2006 Dec; 100(12):1955-64. PubMed ID: 17083978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Synthesis and anticancer activity of [2-hydroxy-1,3-diaminopropane-kappa 2N,N'] platinum(II) complexes.
    Liu W; Chen X; Xie M; Lou L; Ye Q; Yu Y; Hou S
    J Inorg Biochem; 2008 Oct; 102(10):1942-6. PubMed ID: 18707762
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platinated copper(3-clip-phen) complexes as effective DNA-cleaving and cytotoxic agents.
    Ozalp-Yaman S; de Hoog P; Amadei G; Pitié M; Gamez P; Dewelle J; Mijatovic T; Meunier B; Kiss R; Reedijk J
    Chemistry; 2008; 14(11):3418-26. PubMed ID: 18293353
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cisplatinum and transplatinum complexes with benzyliminoether ligands; synthesis, characterization, structure-activity relationships, and in vitro and in vivo antitumor efficacy.
    Sbovata SM; Bettio F; Mozzon M; Bertani R; Venzo A; Benetollo F; Michelin RA; Gandin V; Marzano C
    J Med Chem; 2007 Sep; 50(19):4775-84. PubMed ID: 17713897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Thermodynamic and kinetic data for adduct formation, cis-trans isomerization and redox reactions of ML4 complexes: a case study with rhodium- and iridium-tropp complexes in d8, d9 and d10 valence electron configurations (tropp=dibenzotropylidene phosphanes).
    Breher F; Rüegger H; Mlakar M; Rudolph M; Deblon S; Schönberg H; Boulmaâz S; Thomaier J; Grützmacher H
    Chemistry; 2004 Feb; 10(3):641-53. PubMed ID: 14767928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. 1,4,7,10-tetraazacyclododecane metal complexes as potent promoters of carboxyester hydrolysis under physiological conditions.
    Subat M; Woinaroschy K; Anthofer S; Malterer B; König B
    Inorg Chem; 2007 May; 46(10):4336-56. PubMed ID: 17444638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insights into the molecular mechanisms of protein platination from a case study: the reaction of anticancer platinum(II) iminoethers with horse heart cytochrome c.
    Casini A; Gabbiani C; Mastrobuoni G; Pellicani RZ; Intini FP; Arnesano F; Natile G; Moneti G; Francese S; Messori L
    Biochemistry; 2007 Oct; 46(43):12220-30. PubMed ID: 17924668
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro and in vivo antitumor activity of platinum(II) complexes with thiosemicarbazones derived from 2-formyl and 2-acetyl pyridine and containing ring incorporated at N(4)-position: synthesis, spectroscopic study and crystal structure of platinum(II) complexes with thiosemicarbazones, potential anticancer agents.
    Kovala-Demertzi D; Papageorgiou A; Papathanasis L; Alexandratos A; Dalezis P; Miller JR; Demertzis MA
    Eur J Med Chem; 2009 Mar; 44(3):1296-302. PubMed ID: 18848372
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [1H, 15N] heteronuclear single quantum coherence NMR study of the mechanism of aquation of platinum(IV) ammine complexes.
    Davies MS; Hall MD; Berners-Price SJ; Hambley TW
    Inorg Chem; 2008 Sep; 47(17):7673-80. PubMed ID: 18671390
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tuning the hydrolytic aqueous chemistry of osmium arene complexes with N,O-chelating ligands to achieve cancer cell cytotoxicity.
    Peacock AF; Parsons S; Sadler PJ
    J Am Chem Soc; 2007 Mar; 129(11):3348-57. PubMed ID: 17319668
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Sterically hindered complexes of platinum(II) with planar heterocyclic nitrogen donors. A novel complex with 1-methyl-cytosine has a spectrum of activity different from cisplatin and is able of overcoming acquired cisplatin resistance.
    Margiotta N; Natile G; Capitelli F; Fanizzi FP; Boccarelli A; De Rinaldis P; Giordano D; Coluccia M
    J Inorg Biochem; 2006 Nov; 100(11):1849-57. PubMed ID: 16959321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cationic nonsymmetric transplatinum complexes with piperidinopiperidine ligands. Preparation, characterization, in vitro cytotoxicity, in vivo toxicity, and anticancer efficacy studies.
    Najajreh Y; Khazanov E; Jawbry S; Ardeli-Tzaraf Y; Perez JM; Kasparkova J; Brabec V; Barenholz Y; Gibson D
    J Med Chem; 2006 Jul; 49(15):4665-73. PubMed ID: 16854072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structural characterization and DNA interactions of new cytotoxic transplatin analogues containing one planar and one nonplanar heterocyclic amine ligand.
    Najajreh Y; Kasparkova J; Marini V; Gibson D; Brabec V
    J Biol Inorg Chem; 2005 Nov; 10(7):722-31. PubMed ID: 16208494
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of chemosensitivity and resistance of human cancer cell lines to platinum(II) versus platinum(IV) anticancer agents.
    Hamberger J; Liebeke M; Kaiser M; Bracht K; Olszewski U; Zeillinger R; Hamilton G; Braun D; Bednarski PJ
    Anticancer Drugs; 2009 Aug; 20(7):559-72. PubMed ID: 19491657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Dinuclear alkyldiamine platinum antitumor compounds: a structure-activity relationship study.
    Jansen BA; van der Zwan J; den Dulk H; Brouwer J; Reedijk J
    J Med Chem; 2001 Jan; 44(2):245-9. PubMed ID: 11170634
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Loss of amine from platinum(II) complexes: implications for cisplatin inactivation, storage, and resistance.
    Lau JK; Deubel DV
    Chemistry; 2005 Apr; 11(9):2849-55. PubMed ID: 15744707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis, spectroscopy and antiproliferative activity of cis- and trans-platinum(II) complexes with diethyl (pyridin-4-ylmethyl)phosphate. X-ray crystal structure of trans-Pt(II) complex.
    Kalinowska U; Matławska K; Checińska L; Domagała M; Kontek R; Osiecka R; Ochocki J
    J Inorg Biochem; 2005 Oct; 99(10):2024-31. PubMed ID: 16111760
    [TBL] [Abstract][Full Text] [Related]  

  • 40. New water-soluble platinum(II) phenanthroline complexes tested as cisplatin analogues: First-time comparison of cytotoxic activity between analogous four- and five-coordinate species.
    De Pascali SA; Migoni D; Papadia P; Muscella A; Marsigliante S; Ciccarese A; Fanizzi FP
    Dalton Trans; 2006 Nov; (42):5077-87. PubMed ID: 17060994
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.